Systemic Diseases of Connective Tissue M.Valešová.

Slides:



Advertisements
Similar presentations
Connective tissue disorders Systemic lupus erythematosus
Advertisements

Lupus in Pregnancy Darren Farley, MD Clinical Assistant Professor
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
(SLE).  Definition  Epidemiology  Pathophysiology  Clinical features  Classification and diagnosis  Treatment  Prognosis  Lupus related syndromes.
Sytemic Lupus Erythematosis The New Understanding: Complexity and Promise Jan L Hillson MD.
1 IN THE NAME OF GOD. 2 SYSTEMIC LUPUS ERYTHEMATOSIS (SLE)
DR SANTOSH KUMAR ASSISTANT PROFESSOR MEDICINE UNTI 2.
Immune Complex Nephritis.
LUPUS IN MEN. SLE: IMMUNOLOGIC FACTORS HALLMARK: POLYCLONAL IMMUNE HYPERACTIVITY WITH INCREASED PRODUCTION OF ANTIBODIES AGAINST “SELF” CONSTITUENTS.
Immunology Stack Slackers Facts by Mike Ori. Disclaimer The information represents my understanding only so errors and omissions are probably rampant.
Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.
Dr. Meg-angela Christi Amores
Systemic Lupus Erythematosus
Focus on Systemic Lupus Erythematosus (SLE)
Department of Pathology
Dr Shoaib Raza.   Immune reactions against self antigens  Affects 1% to 2% of US population  Requirements for an autoimmune disorder:  Presence of.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student under Nephrology Division under the supervision and administration.
Systemic Lupus Erythematosis. The Immune System Immunology Connection to Tissue Engineering Develop methods to selectively block immune response to engineered.
Clinical Immunology Conleth Feighery John Jackson.
No history of arthritis Significant cardiomegaly on chest x-ray
Oct. 14 There is no evidence of bowel obstruction or dilatation. 1. Extensive axillary, mediastinal, abdominal, pelvic lymphadenopathy, as above, most.
Image From collection/systemic_lupus_erythematosus_1_picture/pict ure.htm.
Systemic Lupus Erythematosus. Systemic Lupus Erythematosus (SLE) Multisystemic inflammatory chronic disease characterized by inflammation of blood vessels.
Interventions for Clients with Connective Tissue Disease and Other Types of Arthritis.
Naomi Sen.  Aim ◦ To give an outline of the diagnosis and management of SLE  Objectives ◦ To describe signs and symptoms of SLE ◦ To outline relevant.
Systemic Lupus Erythematosus. Intended Learning Objectives (ILOs) Identify definition and causes of SLE.Identify definition and causes of SLE. Understand.
Chapter 2 Immunity and the Lymphatic System. Elsevier items and derived items © 2009 by Saunders, an imprint of Elsevier Inc. 1 Immunity  Immunity: The.
The Integumentary System. Functions Covering Regulation Manufacturing Stimulation Storage Screening Absorbtion.
PhD. student kefah F.Hasson 2014 Hypersensitivity Reactions type III.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Good Morning ! October 3 rd,  An overlap syndrome associated with anti-U1-RNP (ribonucleic protein) antibodies with features of SLE, scleroderma,
Diagnostic Approach to Vasculitis
Immune Complex Nephritis
September 24,  20% diagnosed in childhood  Mostly in adolescence  F:M ratio  Prior to puberty - 3:1  After puberty - 9:1  Native Americans.
Part B Autoimmune Diseases Part B Autoimmune Diseases Effector mechanisms of autoimmune disease Endocrine glands as special targets.
Vasculitis.
And Review of Acute nephritis Syndromes. Karyomegalic Tubulointerstitial Nephritis  Symptoms: Recurrent Pneumonias Renal failure leading invariably to.
By: Rian Asmeida Farha binti Ahmad Rejab Wan Fadhilah binti Wan Ibrahim S YSTEMIC L UPUS E RYTHEMATOSUS (SLE)
AUTOIMMUNITY-I,II, III PRACTICAL 4. l Case No 1 l A 25-year-old woman has had increasing malaise, a skin rash of her face exacerbated by sunlight exposure,
Mixed Connective Tissue Disease
R HEUMATOID F ACTOR ( RF ). Rheumatoid arthritis is a chronic inflammatory disorder that affects all joints either in hands or feet and other areas of.
AUTOIMMUNITY. Autoimmunity Breaking of self tolerance Both B and T cells may be involved (however, most are antibody mediated)
Sarra Abdurrezag Esharik Systemic Lupus Erythematosus (SLE)
Systemic Sclerosis (Scleroderma)
Mechanisms of Autoimmunity Immunology Unit Department of Pathology College of Medicine.
Type I. „immediate” Type II.Type III.Type IV. „late” Antibody mediatedT cell mediated AN OVERVIEW OF HYPERSENSITIVITY REACTIONS.
Chapter 5 : Diseases of the Immune System Department of Pathology Peking Union Medical College Lu Zhaohui.
Systemic Lupus Erythematosus
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
AUTOIMMUNITY- III. Autoimmunity Part-III l At the end of the session the student should be able to: l a. Describe the pathogenesis of important autoimmune.
Autoimmunity and Autoimmune Disease
Systemic Lupus Erythematosus (SLE). SLE Lupus is the latin word for “WOLF” Is an autoimmune disorder characterized by inflammation of almost any body.
Systemic Sclerosis (Scleroderma)
Autoimmune Disorders During Pregnancy -Lupus -Antiphospholipid syndrome Rovnat Babazade, MD Obstetrical Anesthesia-2016.
Systemic Lupus Erythematosus
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) BY DR WAQAR MBBS, MRCP ASST. PROFESSOR.
“Mixed Connective Tissue Disease: Still Crazy After All These Years”
Systemic Lupus Erythematosis
Systemic Lupus Erythematosus
ILOs of the second lecture
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Sytemic Lupus Erythematosus
AUTOIMMUNE DISEASES.
Nephrology cases Dr . Hayam Hebah.
Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine
Advanced Adult Health Ashanti Starr Johnson, BSN, RN
Presentation transcript:

Systemic Diseases of Connective Tissue M.Valešová

The term „connective tissue diseases“ describe a group of conditions characterised by the occurrence of: The term „connective tissue diseases“ describe a group of conditions characterised by the occurrence of: vasculitis vasculitis multisystem involvement multisystem involvement arthritis or artralgia arthritis or artralgia abnormal immunological features abnormal immunological features (autoantibodies, immune complexes deposition ) (autoantibodies, immune complexes deposition )

Systemic Diseases of Connective Tissue Systemic lupus erythematosus (SLE) Systemic lupus erythematosus (SLE) Rheumatoid arthritis Rheumatoid arthritis Sj ő gren´s syndroma Sj ő gren´s syndroma Systemic sclerosis Systemic sclerosis Dermatomyositis, Myositis Dermatomyositis, Myositis Vasculitis Vasculitis

Systemic Diseases of Connective Tissue The aetiology is unknown Environmetal factors Environmetal factors - exposure to sunlight - exposure to sunlight - viral infections - viral infections - drugs - lupus-like syndroma - drugs - lupus-like syndroma (hydrallazine, isoniazid, contraceptives) (hydrallazine, isoniazid, contraceptives) Genetics-markers DR2 and DR3 Genetics-markers DR2 and DR3

Systemic Diseases of Connective Tissue Connective tissue iscomposed essentially of collagen,elastic fibres and fibroblasts in anamorphous ground substance Common features of this diseases: Vascular pathology and fibrinoid changes in the ground substance Vascular pathology and fibrinoid changes in the ground substance Many clinical features in common, difficulty to make a diagnosis Many clinical features in common, difficulty to make a diagnosis

Systemic Diseases of Connective Tissue Deposition of immune complex in tissue results in: Deposition of immune complex in tissue results in: - glomerulonefritis- in glomerular basement membrane membrane - vasculitis – in blood vessels - arthritis – in joint synovium

Systemic Diseases of Connective Tissue Complement activation results in: Depresion of circulating complement Depresion of circulating complement Activation of coagulation system and depression of circulating plateled levels Activation of coagulation system and depression of circulating plateled levels Chemotaxis of PMN(polymorphonuclear leukocytese) Chemotaxis of PMN(polymorphonuclear leukocytese) Release of vasoactive substances(histamine ) Release of vasoactive substances(histamine ) Cytolysis Cytolysis

Systemic lupus erythematosus (SLE) SLE is a complex multi-system autoimmune disease is a complex multi-system autoimmune disease Involved organs: Skin Skin Heart Heart Vessels Vessels Kidney Kidney CNS CNS

Systemic lupus erythematosus (SLE) The primary pathology is that of multisystem inflammatory process, probably secondary to The primary pathology is that of multisystem inflammatory process, probably secondary to antigen-antibody reactions antigen-antibody reactions Hyperactivity of B lymphocytes- production of antibodies againts nuclear antigens.: ANA, anti-ds DNA, anti-Sm Hyperactivity of B lymphocytes- production of antibodies againts nuclear antigens.: ANA, anti-ds DNA, anti-Sm

SLE-Aetiology Unknown Unknown Aetiological role of enviromental factors,such as -exposure to sunlight Aetiological role of enviromental factors,such as -exposure to sunlight Viral infection (EBV, CMV, retroviruses) Viral infection (EBV, CMV, retroviruses) Increased concentration of prolactin and estrogens Increased concentration of prolactin and estrogens Some drugs produces lupus-like syndrome (hydrallazin,isoniazid,oral contraceptives) Some drugs produces lupus-like syndrome (hydrallazin,isoniazid,oral contraceptives)

SLE -pathogeneses The primary pathology is that of multisystem inflammatory process probably secondary to antigen-antibody reaction,autoimmunity The primary pathology is that of multisystem inflammatory process probably secondary to antigen-antibody reaction,autoimmunity vasculitis and vasculopathy vasculitis and vasculopathy Almost all patients possess an antibody against nuclear antigens(ANA)-nonspecific marker,antibodies anti –dsDNA,antiSm-more specific for SLE Almost all patients possess an antibody against nuclear antigens(ANA)-nonspecific marker,antibodies anti –dsDNA,antiSm-more specific for SLE

Systemic lupus erythematosus (SLE) - clinical findings The most constant features: Fever, Fever, Arthritis or arthralgia Arthritis or arthralgia Skin rashes Skin rashes Polyserositis Polyserositis

Systemic lupus erythematosus (SLE)- clinical findings Constitutional syptoms- anorexia,tiredness,fever,weight loss Constitutional syptoms- anorexia,tiredness,fever,weight loss Many organ systems may be involved Many organ systems may be involved

Systemic lupus erythematosus (SLE) Skin involvement rash – erythematosus lessions rash – erythematosus lessions - discoid lessions - discoid lessions photosensitivity photosensitivity urtica urtica various exanthemas various exanthemas

Systemic lupus erythematosus Skin involvement

Systemic lupus erythematosus Skin involvement Systemic lupus erythematosus Skin involvement

Systemic lupus erythematosus Skin involvement ( 80% patients) Rash may occur in sun exposed areas

Systemic lupus erythematosus (SLE) Heart involvement Endo,myo,peri carditis Endo,myo,peri carditis Pericarditis with efusion- ECHO Pericarditis with efusion- ECHO Vasculopathy of coronary arterias ( atherosclerosis) Vasculopathy of coronary arterias ( atherosclerosis)

Systemic lupus erythematosus (SLE) Pleuri sy ( effusion ) Pleuri sy ( effusion ) Acute pneumonitid is – vas c uliti s of lung Acute pneumonitid is – vas c uliti s of lung vessels vessels Pulmonary infarcts Pulmonary infarcts

Systemic lupus erythematosus (SLE) Central nervous system involvement. Increasingly important manifestation develops later than renal disease Seizures Seizures Focal neurologic signs Focal neurologic signs Organic brain syndrome Organic brain syndrome Non organic mental disorders Non organic mental disorders

Systemic lupus erythematosus (SLE) Renal involvement : glomerulonefritis glomerulonefritis Mesangial type-mesangial deposition of immune complexes Mesangial type-mesangial deposition of immune complexes Focal proliferative type –local thickening Focal proliferative type –local thickening Diffuse proliferative type Diffuse proliferative type thickening of glomerular basement membrane, thickening of glomerular basement membrane, masive deposition of immunocomplexes subepithelialy masive deposition of immunocomplexes subepithelialy Membranous type Membranous type

Systemic lupus erythematosus (SLE) Renal involvement Proteinurie, mi c rohematurie Proteinurie, mi c rohematurie Nefrotic syndrom a Nefrotic syndrom a Renal hypertension Renal hypertension Renal insuficiency Renal insuficiency

Systemic lupus erythematosus (SLE) Joint involvement Arthralgias Arthralgias Arthritis- may resemble RA Arthritis- may resemble RA

Systemic lupus erythematosus(SLE) Blood involvement Hemolytic anemia Leukopenia or lymphopenia Trombocytopenia Lymfadenopthy Trombotic tendency

Systemic lupus erythematosus(SLE) Blood involvement Trombotic tendency are more marked in patients with positive Anticardiolipin antibodies ACLA Anti-phospholipid antibodies „Lupus anticoagulans“

Systemic lupus erythematosus(SLE) Investigations: increased : ESR,CRP immunoglobulins positivity : ANA ( 90% pts) anti ds- DNA sublclasses of ANA- anti - Ro anti - Sm

Systemic lupus erythematosus(SLE) Theraphy: Mild disease – skin, joints ´ – hydroxychloroqine (Plaquenil) Active disease – systemic steroids - immunosupressive agents (Methotrexate, cyclophosphamide azathioprim,

Systemic Sclerosis (S Sc ) Uncommon idiophatic multisystem disease Predominantly affects the skin and blood vessels Female preponderance 3:1 Main pathological feature-progressive fibrosis and atrophy 2 types – diffuse localised Typhical autoantibody

Systemic Sclerosis (S Sc ) The skin is thickned and tight and this results in contractures The skin is thickned and tight and this results in contractures Raynaud´s phenomenon in 95% pts Raynaud´s phenomenon in 95% pts Organs involvement- GIT, lung,kidney Organs involvement- GIT, lung,kidney

Systemic Sclerosis (S Sc )

D ermatomyo sitis and Polymyoi sits

Sj ő gren´s syndrom e

Dryness of the eyes(sicca syndrome) Dryness of the eyes(sicca syndrome) Dryness of the mouth (xerostomia) Dryness of the mouth (xerostomia) Caused by chronic dysfunction of the exocrine glands It may occur alone or in assotiation with RA or other connective tissue disorders